ChengDa Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and food and feed additives in China and internationally. It offers APIs; bulk drugs for urogenital, musculoskeletal system, and antineoplastic and immunomodulators; and drug intermediates for blood and hematopoietic organs, digestive tract and metabolism, and nervous system. The company was founded in 1980 and is based in Jiaxing, China.